Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey

, Antonin Levy*, Lizza E. L. Hendriks, Cecile Le Pechoux, Sally Falk, Benjamin Besse, Silvia Novello, Anne-Marie C. Dingemans, Baktiar Hasan, Martin Reck, Thierry Berghmans, Corinne Faivre-Finn

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)145-147
Number of pages3
JournalLung Cancer
Volume136
DOIs
Publication statusPublished - Oct 2019
Event38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) - Barcelona, SPAIN, Milan, Italy
Duration: 26 Apr 201930 Apr 2019
Conference number: 37

Keywords

  • Small-cell lung cancer
  • Limited-stage
  • Thoracic radiotherapy
  • Fractionation
  • THORACIC RADIOTHERAPY
  • IRRADIATION

Cite this

Levy, Antonin ; Hendriks, Lizza E. L. ; Le Pechoux, Cecile ; Falk, Sally ; Besse, Benjamin ; Novello, Silvia ; Dingemans, Anne-Marie C. ; Hasan, Baktiar ; Reck, Martin ; Berghmans, Thierry ; Faivre-Finn, Corinne. / Current management of limited-stage SCLC and CONVERT trial impact : Results of the EORTC Lung Cancer Group survey. In: Lung Cancer. 2019 ; Vol. 136. pp. 145-147.
@article{c624ded4a8854d07a566efeb8c533f25,
title = "Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey",
keywords = "Small-cell lung cancer, Limited-stage, Thoracic radiotherapy, Fractionation, THORACIC RADIOTHERAPY, IRRADIATION",
author = "Antonin Levy and Hendriks, {Lizza E. L.} and {Le Pechoux}, Cecile and Sally Falk and Benjamin Besse and Silvia Novello and Dingemans, {Anne-Marie C.} and Baktiar Hasan and Martin Reck and Thierry Berghmans and Corinne Faivre-Finn",
year = "2019",
month = "10",
doi = "10.1016/j.lungcan.2019.08.007",
language = "English",
volume = "136",
pages = "145--147",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",

}

Levy, A, Hendriks, LEL, Le Pechoux, C, Falk, S, Besse, B, Novello, S, Dingemans, A-MC, Hasan, B, Reck, M & Berghmans, T & Faivre-Finn, C 2019, 'Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey', Lung Cancer, vol. 136, pp. 145-147. https://doi.org/10.1016/j.lungcan.2019.08.007

Current management of limited-stage SCLC and CONVERT trial impact : Results of the EORTC Lung Cancer Group survey. /; Levy, Antonin; Hendriks, Lizza E. L.; Le Pechoux, Cecile; Falk, Sally; Besse, Benjamin; Novello, Silvia; Dingemans, Anne-Marie C.; Hasan, Baktiar; Reck, Martin; Berghmans, Thierry; Faivre-Finn, Corinne.

In: Lung Cancer, Vol. 136, 10.2019, p. 145-147.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Current management of limited-stage SCLC and CONVERT trial impact

T2 - Results of the EORTC Lung Cancer Group survey

AU - Levy, Antonin

AU - Hendriks, Lizza E. L.

AU - Le Pechoux, Cecile

AU - Falk, Sally

AU - Besse, Benjamin

AU - Novello, Silvia

AU - Dingemans, Anne-Marie C.

AU - Hasan, Baktiar

AU - Reck, Martin

AU - Berghmans, Thierry

AU - Faivre-Finn, Corinne

PY - 2019/10

Y1 - 2019/10

KW - Small-cell lung cancer

KW - Limited-stage

KW - Thoracic radiotherapy

KW - Fractionation

KW - THORACIC RADIOTHERAPY

KW - IRRADIATION

U2 - 10.1016/j.lungcan.2019.08.007

DO - 10.1016/j.lungcan.2019.08.007

M3 - Article

VL - 136

SP - 145

EP - 147

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -